An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Overview of attention for article published in Orphanet Journal of Rare Diseases, December 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#2 of 3,051)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 93 news outlets
blogs: 3 blogs
twitter: 9 X users

facebook: 1 Facebook page
wikipedia: 2 Wikipedia pages
reddit: 1 Redditor

Citations

dimensions_citation: 99 Dimensions

Readers on

mendeley: 184 Mendeley

Summary News Blogs X Facebook Wikipedia Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

Combination of drugs shows promise for CMT1a in preliminary human trial

User NixyeNox, in the CMT subreddit, 20 Dec 2014

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.